EQS-News: BRAIN Biotech AG / Key word(s): Quarterly / Interim Statement3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 28.02.2024 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.3M FY 23/24: BRAIN Biotech looks optimistic to.
EQS-News: BRAIN Biotech AG / Key word: Quarterly / Interim Statement
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24.
EQSAdhoc Kontron AG Key word Mergers & Acquisitions Adhoc Kontron AG LinzAustria Closing conditions met for the acquisition of around 59% of the shares in KATEK SE 28Feb2024 1200 CETCEST Disclosu
EQS-Ad-hoc: Kontron AG / Key word: Mergers & Acquisitions
Adhoc: Kontron AG, Linz/Austria, Closing conditions met for the acquisition of around 59% of the shares in KATEK SE
28-Feb-2024 /.